Impacts on Quality of Life with Escitalopram Monotherapy and Aripiprazole Augmentation in Patients with Major Depressive Disorder: A CAN-BIND Report

Discussion Individuals who were treated with adjunctive aripiprazole after non-response to escitalopram experienced improved QoL, but a substantial degree of QoL impairment persisted. Since QoL deficits may predict MDD recurrence, attention to ways to support this outcome is required. [...] Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, GermanyArticle in Thieme eJournals: Table of contents  |  Abstract  |  Full text

Source: Pharmacopsychiatry - March 2, 2021 Category: Psychiatry Authors: Morton, Emma Bhat, Venkat Giacobbe, Peter Lou, Wendy Michalak, Erin E. Chakrabarty, Trisha Frey, Benicio N. Milev, Roumen V. M üller, Daniel J. Parikh, Sagar V. Rotzinger, Susan Kennedy, Sidney H. Lam, Raymond W. Tags: Original Paper Source Type: research